Published in Rev Infect Dis on April 15, 1983
Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect Immun (1986) 5.92
Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J Clin Invest (1986) 2.91
Genetics of spontaneous, high-frequency loss of b capsule expression in Haemophilus influenzae. Infect Immun (1985) 2.84
Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev (1998) 2.24
Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae. Infect Immun (1986) 2.20
Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J Clin Invest (1985) 2.09
Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun (1987) 1.87
Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system. Infect Immun (1985) 1.85
Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect Immun (1987) 1.82
Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect Immun (1988) 1.81
The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect Immun (1991) 1.75
Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect Immun (1987) 1.59
Genetic identification of cryptic genospecies of Haemophilus causing urogenital and neonatal infections by PCR using specific primers targeting genes coding for 16S rRNA. J Clin Microbiol (1996) 1.50
Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun (1991) 1.48
Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol (2003) 1.46
A recombinant non-fatty acylated form of the Hi-PAL (P6) protein of Haemophilus influenzae elicits biologically active antibody against both nontypeable and type b H. influenzae. Infect Immun (1990) 1.42
Genetic characterization of a cryptic genospecies of Haemophilus causing urogenital and neonatal infections. J Clin Microbiol (1993) 1.41
Typing of urogenital, maternal, and neonatal isolates of Haemophilus influenzae and Haemophilus parainfluenzae in correlation with clinical source of isolation and evidence for a genital specificity of H. influenzae biotype IV. J Clin Microbiol (1989) 1.29
Classification, identification, and clinical significance of haemophilus and aggregatibacter species with host specificity for humans. Clin Microbiol Rev (2014) 1.20
Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun (1994) 1.16
In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates. Antimicrob Agents Chemother (1988) 1.09
Nucleotide sequences of genes coding for fimbrial proteins in a cryptic genospecies of Haemophilus spp. isolated from neonatal and genital tract infections. Infect Immun (1999) 1.05
Pulmonary persistence of Haemophilus somnus in the presence of specific antibody. J Clin Microbiol (1989) 1.03
Nearest neighbor analysis of outer membrane proteins of nontypeable Haemophilus influenzae. Infect Immun (1988) 1.01
Adherence to human cells of a cryptic Haemophilus genospecies responsible for genital and neonatal infections. Infect Immun (1993) 1.00
Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae. Infect Immun (1996) 0.98
Prevalence of the sodC gene in nontypeable Haemophilus influenzae and Haemophilus haemolyticus by microarray-based hybridization. J Clin Microbiol (2009) 0.98
Characterization of transferrin binding proteins 1 and 2 in invasive type b and nontypeable strains of Haemophilus influenzae. Infect Immun (1995) 0.96
Isolation and biochemical characterization of Haemophilus species isolated simultaneously from the oropharyngeal and anogenital areas. J Clin Microbiol (1989) 0.95
Identification of a Haemophilus influenzae 5'-nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein. Infect Immun (2000) 0.95
Biotypes of Haemophilus influenzae that are associated with noninvasive infections. J Clin Microbiol (1991) 0.94
Identification of Haemophilus influenzae type b by a monoclonal antibody coagglutination assay. J Clin Microbiol (1987) 0.94
Active copper- and zinc-containing superoxide dismutase in the cryptic genospecies of Haemophilus causing urogenital and neonatal infections discriminates them from Haemophilus influenzae sensu stricto. J Clin Microbiol (2002) 0.94
Adhesive activity of the haemophilus cryptic genospecies cha autotransporter is modulated by variation in tandem Peptide repeats. J Bacteriol (2010) 0.92
Identification of a novel trimeric autotransporter adhesin in the cryptic genospecies of Haemophilus. J Bacteriol (2008) 0.91
Comparison of three commercial test systems for biotyping Haemophilus influenzae and Haemophilus parainfluenzae. J Clin Microbiol (2007) 0.90
Participation of complement in host defense against capsule-deficient Haemophilus influenzae. Infect Immun (1983) 0.88
Non-capsulate Haemophilus influenzae: a neglected pathogen in adults. Br Med J (Clin Res Ed) (1985) 0.82
Fimbrial ghf gene cluster of genital strains of Haemophilus spp. Infect Immun (2002) 0.81
Prevalence of early-onset neonatal infection among newborns of mothers with bacterial infection or colonization: a systematic review and meta-analysis. BMC Infect Dis (2015) 0.81
Analysis of pilus adhesins from Haemophilus influenzae biotype IV strains. Infect Immun (2001) 0.81
Neonatal Haemophilus influenzae infections. Arch Dis Child (1991) 0.80
Distribution and relationship to serotype of Haemophilus influenzae biotypes isolated from upper respiratory tracts of children and adults in Papua New Guinea. J Clin Microbiol (1984) 0.80
Cellular immunity to the P6 outer membrane protein of nontypeable Haemophilus influenzae. Infect Immun (1995) 0.79
Haemophilus influenzae septic abortion. Infect Dis Obstet Gynecol (2002) 0.79
Biotypes, serotypes, and susceptibility to antibiotics of 60 Haemophilus influenzae strains from genitourinary tracts. Genitourin Med (1988) 0.78
Neonatal infections with Haemophilus species. Arch Dis Child (1988) 0.78
Occult bacteremia with nontypeable Haemophilus influenzae. J Clin Microbiol (1987) 0.77
The long and the short of bacterial adhesion regulation. J Bacteriol (2010) 0.77
The Haemophilus cryptic genospecies Cha adhesin has at least two variants that differ in host cell binding, bacterial aggregation, and biofilm formation properties. J Bacteriol (2014) 0.76
Haemophilus influenzae Sepsis and Placental Abruption in an Unvaccinated Immigrant. West J Emerg Med (2012) 0.76
Case Report of Haemophilus parainfluenzae Sepsis in a Newborn Infant Following Water Birth and a Review of Literature. AJP Rep (2015) 0.75
Pericarditis caused by beta-lactamase-producing Haemophilus influenzae: report of two cases in adults and review of the literature. Tex Heart Inst J (1986) 0.75
Clinical and microbiological features of Haemophilus influenzae vulvovaginitis in young girls. J Clin Pathol (2002) 0.75
Draft Genome Sequences of Two "Haemophilus quentini" Isolates Recovered from Two Different Patients' Blood Cultures. Genome Announc (2016) 0.75
Bacteremic renal stone-associated urinary tract infection caused by nontypable Haemophilus influenzae: A rare invasive disease in an immunocompetent patient. IDCases (2016) 0.75
Detection of Legionnaires disease bacteria by direct immunofluorescent staining. J Clin Microbiol (1978) 17.69
Primary isolation media for Legionnaires disease bacterium. J Clin Microbiol (1978) 11.86
Cellular fatty acid composition of isolates from Legionnaires disease. J Clin Microbiol (1977) 10.84
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol (1980) 10.44
Chromosomal DNA fingerprint patterns produced with IS6110 as strain-specific markers for epidemiologic study of tuberculosis. J Clin Microbiol (1991) 8.24
Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol (1976) 7.48
Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86
Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr (1973) 6.29
Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis. J Clin Microbiol (1988) 5.97
Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med (1976) 5.78
Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis (1983) 5.66
30 years of campylobacters: biochemical characteristics and a biotyping proposal for Campylobacter jejuni. J Clin Microbiol (1982) 5.19
Rochalimaea elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol (1993) 5.06
Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol (1977) 4.46
Selective broth medium for isolation of group B streptococci. Appl Microbiol (1973) 4.42
Non-cholera vibrio infections in the United States. Clinical, epidemiologic, and laboratory features. Ann Intern Med (1978) 4.28
PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol (1995) 4.27
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother (1985) 4.09
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis (1993) 3.86
Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens. J Clin Microbiol (1979) 3.86
Legionella longbeachae species nova, another etiologic agent of human pneumonia. Ann Intern Med (1981) 3.78
Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother (1992) 3.69
Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol (1995) 3.63
Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations. Clin Infect Dis (1992) 3.61
Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol (1989) 3.59
Unidentified gram-negative rod infection. A new disease of man. Ann Intern Med (1977) 3.53
Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis. J Clin Microbiol (1993) 3.52
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production. J Infect Dis (1981) 3.45
Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40
Cellular fatty acid composition of selected Pseudomonas species. Appl Microbiol (1972) 3.28
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother (1994) 3.28
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Pseudomonas putrefaciens isolates from clinical specimens. Appl Microbiol (1972) 3.21
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1999) 3.16
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis (1985) 3.16
Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis. J Clin Microbiol (1997) 3.12
Identification of Vibrio hollisae sp. nov. from patients with diarrhea. J Clin Microbiol (1982) 3.08
Active oxygen in plant pathogenesis. Annu Rev Phytopathol (1995) 3.02
DNA polymorphisms in strains of Mycobacterium tuberculosis analyzed by pulsed-field gel electrophoresis: a tool for epidemiology. J Clin Microbiol (1992) 2.89
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol (1986) 2.87
Molecular cloning of a Pseudomonas syringae pv. syringae gene cluster that enables Pseudomonas fluorescens to elicit the hypersensitive response in tobacco plants. J Bacteriol (1988) 2.84
Disk diffusion susceptibility testing of Nocardia species. J Infect Dis (1977) 2.77
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother (1979) 2.74
Cellular fatty acid composition of Pseudomonas paucimobilis and groups IIk-2, Ve-1, and Ve-2. J Clin Microbiol (1979) 2.58
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol (1995) 2.50
Involvement of plasma membrane calcium influx in bacterial induction of the k/h and hypersensitive responses in tobacco. Plant Physiol (1990) 2.46
Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr (1993) 2.45
Proposal of Afipia gen. nov., with Afipia felis sp. nov. (formerly the cat scratch disease bacillus), Afipia clevelandensis sp. nov. (formerly the Cleveland Clinic Foundation strain), Afipia broomeae sp. nov., and three unnamed genospecies. J Clin Microbiol (1991) 2.44
Biochemical and chemical characterization of pink-pigmented oxidative bacteria. J Clin Microbiol (1990) 2.41
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol (2001) 2.38
Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun (1976) 2.38
Chemical characterization of Flavobacterium odoratum, Flavobacterium breve, and Flavobacterium-like groups IIe, IIh, and IIf. J Clin Microbiol (1986) 2.38
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis (1998) 2.34
Yersinia enterocolitica. N Engl J Med (1970) 2.34
Analysis of Listeria monocytogenes by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Int J Food Microbiol (1989) 2.29
Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol (1993) 2.28
Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J Clin Microbiol (1985) 2.26
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol (1993) 2.25
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23
Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis (1982) 2.22
Capnocytophaga canimorsus sp. nov. (formerly CDC group DF-2), a cause of septicemia following dog bite, and C. cynodegmi sp. nov., a cause of localized wound infection following dog bite. J Clin Microbiol (1989) 2.22
Serogroups of Campylobacter jejuni, Campylobacter coli, and Campylobacter fetus defined by direct immunofluorescence. J Clin Microbiol (1983) 2.22
Neisseria lactamicus sp. n., a lactose-fermenting species resembling Neisseria meningitidis. Appl Microbiol (1969) 2.22
Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii. Int J Syst Bacteriol (1996) 2.18
Illness caused by Vibrio damsela and Vibrio hollisae. Lancet (1982) 2.17
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol (1995) 2.16
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15
Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures. J Clin Microbiol (1976) 2.14
Cellular fatty acid composition of Campylobacter fetus. J Clin Microbiol (1980) 2.14
Changing epidemiology of group B streptococcal colonization. Pediatrics (1999) 2.09
Amoxicillin-clavulanic acid in the treatment of lower respiratory tract infections caused by beta-lactamase-positive Haemophilus influenzae and Branhamella catarrhalis. Antimicrob Agents Chemother (1985) 2.08
Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks. J Clin Microbiol (1992) 2.07
Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis (1982) 2.06
Immunodeterminant specificity of human immunity to type III group B streptococcus. J Exp Med (1979) 2.06